ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · Real-Time Price · USD
73.89
+1.91 (2.65%)
Oct 9, 2026, 4:00 PM EDT - Market closed
ANI Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Buy Reiterates $119 | Buy | Reiterates | $119 | +61.05% | Oct 6, 2026 |
| Oppenheimer | Oppenheimer | Hold Initiates $85 | Hold | Initiates | $85 | +15.04% | Sep 23, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $121 | Buy | Maintains | $121 | +63.76% | Sep 21, 2026 |
| Leerink Partners | Leerink Partners | Buy Initiates $104 | Buy | Initiates | $104 | +40.75% | Sep 9, 2026 |
| Barclays | Barclays | Buy Maintains $100 | Buy | Maintains | $100 | +35.34% | Aug 26, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Reiterates $120 | Buy | Reiterates | $120 | +62.40% | Aug 10, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates $115 | Buy | Reiterates | $115 | +55.64% | Aug 10, 2026 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $91 → $90 | Hold | Maintains | $91 → $90 | +21.80% | Aug 10, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.